Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China. [electronic resource]
Producer: 20200508Description: 6551-6560 p. digitalISSN:- 2219-2840
- Adult
- Antiviral Agents -- administration & dosage
- China
- Drug Interactions
- Drug Therapy, Combination -- adverse effects
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Liver Cirrhosis -- drug therapy
- Male
- Middle Aged
- Prospective Studies
- Sustained Virologic Response
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.